PCSK9 and familial hypercholesterolemia: We investigated the pharmacodynamics of ZwiLNPs loaded with sihPCSK9 at a lower 1 mg/kg dosage in an HFD-induced PCSK9 humanized transgenic mouse model of hypercholesterolemia.